CONFLICT OF INTEREST
TY TY received honoraria from Sanofi, Mitsubishi Tanabe Pharma, and
Kyorin Pharma, and grant support from Sanofi. SU is an advisory board
member of GlaxoSmithKline K.K. (GSK), received honoraria for lectures
from AstraZeneca K.K. (AZ) GSK and Sanofi, and grant support from AZ,
Novartis Pharma K.K., and Maruho Co. Ltd.